PlainRecalls
CriticalClass ITerminated

FDA Drug recall · Reported February 23, 2022

HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only, Compounded By: Revive Rx 3831 Golf Dr., Houston, TX 77018, NDC: 88888-1739-01.

Non-sterility; bacterial contamination identified as Paenibacillus lautus.

Recall #
D-0648-2022
Affected scope
115 vials
Initiated
February 11, 2022
Verify with FDA Drug →
View my saved recalls

Revive Rx LLC dba Revive Rx Pharmacy recalled HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV… - a critical-severity action.

HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV… was recalled by Revive Rx LLC dba Revive Rx Pharmacy in February 23, 2022. Reason: Non-sterility; bacterial contamination identified as Paenibacillus lautus.. Check the official notice for the remedy. Verify recall #D-0648-2022 with the FDA Drug before acting.

The recall

Revive Rx LLC dba Revive Rx Pharmacy issued this critical-severity FDA Drug recall-Non-sterility; bacterial contamination identified as Paenibacillus lautus..

Critical
severity level
Class I
classification
February 23, 2022
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0648-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This FDA Drug action (record #D-0648-2022) was formally reported on February 23, 2022, with the manufacturer initiating the action on February 11, 2022. It is classified under Critical severity (Class I), with a current status of Terminated. Revive Rx LLC dba Revive Rx Pharmacy is listed as the recalling firm, operating out of Houston, TX. Federal records list the affected scope as 115 vials.

The documented reason for this recall is: Non-sterility; bacterial contamination identified as Paenibacillus lautus. Distribution data in the federal record shows the product reached: Nationwide in the US.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Outdoor & Sports recalls over time

Where this recall sits in its category - 510 outdoor & sports recalls on record

101520253035 20052008201120142017202020232026 27
Severity2487872426High severity (most serious)Moderate severityLow severity
Where this recall sits in the database

Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Severity

Critical

Affected scope

115 vials

Related Recalls

6

0 from same agency

Product description

HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only, Compounded By: Revive Rx 3831 Golf Dr., Houston, TX 77018, NDC: 88888-1739-01.

Reason for recall

Non-sterility; bacterial contamination identified as Paenibacillus lautus.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Critical (Class I)
Status Terminated
Recall number D-0648-2022
Date reported February 23, 2022
Date initiated February 11, 2022
Recalling firm Revive Rx LLC dba Revive Rx Pharmacy
Firm location Houston, TX
Affected scope 115 vials
Distribution Nationwide in the US.

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-0648-2022) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • This is a Class I (high-risk) recall, stop using the product immediately and follow the disposal or return instructions. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only, Compounded By: Revive Rx 3831 Golf Dr., Houston, TX 77018, NDC: 88888-1739-01.. Recalled by Revive Rx LLC dba Revive Rx Pharmacy. Units affected: 115 vials.
Why was this product recalled?
Non-sterility; bacterial contamination identified as Paenibacillus lautus.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 23, 2022. Severity: Critical. Recall number: D-0648-2022.
Where was the recalled product distributed?
Distribution: Nationwide in the US..
How do I check if my product is affected by a recall?
Check the product description and recall number (D-0648-2022) against your product. Visit the official FDA Drug website for the most current information. You can also use our Recall Checker tool to search by product name or brand.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nearby Recalls in This Category

Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.

Compare this recall with Topyond Pool Drain Ports with Covers Recalled Due to Risk o… →

Browse all Outdoor & Sports recalls →

Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 23, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.